Woltering EA - Search Results

1

Consensus statement: octreotide dose titration in secretory diarrhea. Diarrhea Management Consensus Development Panel.

Harris AG, O'Dorisio TM, Woltering EA, Anthony LB, Burton FR, Geller RB, Grendell JH, Levin B, Redfern JS. Harris AG, et al. Among authors: woltering ea. Dig Dis Sci. 1995 Jul;40(7):1464-73. doi: 10.1007/BF02285194. Dig Dis Sci. 1995. PMID: 7628270 Review.

2

Effect of octreotide LAR dose and weight on octreotide blood levels in patients with neuroendocrine tumors.

Woltering EA, Mamikunian PM, Zietz S, Krutzik SR, Go VL, Vinik AI, Vinik E, O'Dorisio TM, Mamikunian G. Woltering EA, et al. Pancreas. 2005 Nov;31(4):392-400. doi: 10.1097/01.mpa.0000186249.89081.0d. Pancreas. 2005. PMID: 16258376

3

Long-term efficacy of octreotide in the treatment of Zollinger-Ellison syndrome.

Mozell EJ, Cramer AJ, O'Dorisio TM, Woltering EA. Mozell EJ, et al. Among authors: woltering ea. Arch Surg. 1992 Sep;127(9):1019-24; discussion 1024-6. doi: 10.1001/archsurg.1992.01420090023004. Arch Surg. 1992. PMID: 1514904

4

Non-endocrine applications of somatostatin and octreotide acetate: facts and flights of fancy.

Mozell EJ, Woltering EA, O'Dorisio TM. Mozell EJ, et al. Among authors: woltering ea. Dis Mon. 1991 Dec;37(12):749-848. doi: 10.1016/s0011-5029(05)80015-x. Dis Mon. 1991. PMID: 1683832 Review.

5

Calcium reverses octreotide inhibition of insulin and glucagon levels in patients with insulinoma and glucagonoma.

Thompson CS, O'Dorisio TM, Woltering EA. Thompson CS, et al. Among authors: woltering ea. Digestion. 1996;57 Suppl 1:62-8. doi: 10.1159/000201399. Digestion. 1996. PMID: 8813473 Clinical Trial.

6

A prospective trial on the effect of body mass index and sex on plasma octreotide levels in patients undergoing long-term octreotide LAR therapy.

Joseph S, Li G, Lindholm E, Zhou Y, Go VL, Vinik AI, O'Dorisio TM, Mamikunian G, Woltering EA. Joseph S, et al. Among authors: woltering ea. Pancreas. 2010 Oct;39(7):964-6. doi: 10.1097/MPA.0b013e3181db01a8. Pancreas. 2010. PMID: 20467346 Free PMC article.

7

Validation of serum versus plasma measurements of chromogranin a levels in patients with carcinoid tumors: lack of correlation between absolute chromogranin a levels and symptom frequency.

Woltering EA, Hilton RS, Zolfoghary CM, Thomson J, Zietz S, Go VL, Vinik AI, Vinik E, O'Dorisio TM, Mamikunian G. Woltering EA, et al. Pancreas. 2006 Oct;33(3):250-4. doi: 10.1097/01.mpa.0000235302.73615.d4. Pancreas. 2006. PMID: 17003646

8

Treatment of nonendocrine gastrointestinal disorders with octreotide acetate.

Woltering EA, O'Dorisio TM, Williams ST, Lebrado L, Fletcher WS. Woltering EA, et al. Metabolism. 1990 Sep;39(9 Suppl 2):176-9. doi: 10.1016/0026-0495(90)90240-d. Metabolism. 1990. PMID: 1976212 Review.

9

High-dose indium 111In pentetreotide radiotherapy for metastatic atypical carcinoid tumor.

Meyers MO, Anthony LB, McCarthy KE, Drouant G, Maloney TJ, Espanan GD, Woltering EA. Meyers MO, et al. Among authors: woltering ea. South Med J. 2000 Aug;93(8):809-11. South Med J. 2000. PMID: 10963516

10

Clinical value of monitoring plasma octreotide levels during chronic octreotide long-acting repeatable therapy in carcinoid patients.

Woltering EA, Salvo VA, O'Dorisio TM, Lyons J 3rd, Li G, Zhou Y, Seward JR, Go VL, Vinik AI, Mamikunian P, Mamikunian G. Woltering EA, et al. Pancreas. 2008 Jul;37(1):94-100. doi: 10.1097/MPA.0b013e31816907ab. Pancreas. 2008. PMID: 18580450 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

163 results

Search Page

Filters